FT Global Pharmaceutical and Biotechnology Conference 2015
Bringing Innovation to Patients: New Approaches, Models, Challenges
As the global healthcare industry shifts and transforms, so too must the life science industry. Life science companies will need to adjust strategies to a world in which only true innovation and improved patient outcomes become the key determinant of value in the healthcare system. They will also need to develop commercial models which take account of the changing power balance between provider, payer and patients-all the while keeping a watchful eye on the competitive landscape for the incursion of non-traditional players with whom they will increasingly compete-or partner- to deliver patient-centred products and services. Meanwhile, scrutiny of high prices for speciality drugs and advanced technologies is increasing, impacting the ability of life science companies to bring much needed innovation to patients.
To find out more about the FT Global Pharmaceutical and Biotechnology Conference 2015, visit their website.
If you’d like to arrange a meeting with the Results Healthcare team during the conference, please get in touch.